Charles Miller, MD PhD
EyeBiotech Ltd.
3
0
0
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Xiaorong Li, professor
Tianjin Medical University Eye Hospital
Shared therapeutic areas:
Thomas A. Ciulla, MD
Midwest Eye Institute
Shared therapeutic areas:
Louis Glazer, MD
Vitreo-Retinal Associates
Shared therapeutic areas:
Robert S. Wirthlin, MD
Spokane Eye Clinic
Shared therapeutic areas:
Laura Trusso
Bausch & Lomb Incorporated
Shared therapeutic areas:
Brian B. Berger, MD
Retina Research Center
Shared therapeutic areas:
Michael J. Elman, MD
Elman Retina Group
Shared therapeutic areas:
Prema Abraham, MD
Black Hills Regional Eye Institute
Shared therapeutic areas:
Michael J. Tolentino, MD
Center for Retina Macula Disease
Shared therapeutic areas:
Pablo Velazquez-Martin, MD
Kodiak Sciences Inc
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO
A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME
A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME
All 3 trials loaded